Adjuvant treatment; Diagnostic work-up; Endometrial cancer; Pathology; Patterns of care; Population-based; Quality of care; Staging; Surgical treatment; Time trends; Treatment patterns; Uterine cancer; Oncology; Obstetrics and Gynecology
Abstract :
[en] [en] OBJECTIVES: To investigate the practice patterns and quality of care for uterine cancer on a national level in Belgium, including trends in practice over the period 2012-2016.
METHODS: Quality indicators were measured using the EFFectiveness of Endometrial Cancer Treatment (EFFECT) database. Multivariable logistic mixed regression was used to test for associations between the quality indicators and year of diagnosis, adjusted for potential confounders and intra-cluster correlations.
RESULTS: The EFFECT database includes 4178 patients diagnosed with uterine cancer in the period 2012-2016. Minimally invasive surgery (laparoscopic or robotic-assisted) was applied in 61.6% of patients who had surgery for clinical stage I endometrial carcinoma (EC), increasing from 52.9% in 2012 to 66.4% in 2016. At least pelvic lymph node staging was performed in 69.0% of patients with clinical stage I, high-grade EC; and in 63.9% of patients with clinical stage I-II serous carcinoma, clear cell carcinoma or carcinosarcoma. The latter increased from 48.8% in 2012 to 77.2% in 2016. Adjuvant radiotherapy (external beam and/or brachytherapy) was offered to 33.5% of patients who had surgery without lymph node staging for pathological stage I EC at high-intermediate or high risk of recurrence. Adjuvant chemotherapy was administered to 64.4% of patients with pathological stage III-IVA EC.
CONCLUSIONS: Study results indicate an overall good quality of care for patients with uterine cancer in Belgium. Treatment areas with potential room for improvement include the use of minimally invasive surgery, comprehensive surgical staging and adjuvant therapy, which confirms the remaining controversies in uterine cancer treatment and the need for further research.
Disciplines :
Oncology
Author, co-author :
Vanbraband, Joren; Unit of Gynecologic Oncology, Department of Oncology, KU Leuven, Campus Gasthuisberg, ON4 Herestraat 49, Box 1045, 3000 Leuven, Belgium. Electronic address: joren.vanbraband@kuleuven.be
Van Damme, Nancy; Belgian Cancer Registry, Koningsstraat 215, Box 7, 1210 Brussels, Belgium. Electronic address: Nancy.VanDamme@kankerregister.org
Silversmit, Geert; Belgian Cancer Registry, Koningsstraat 215, Box 7, 1210 Brussels, Belgium. Electronic address: geert.silversmit@kankerregister.org
De Geyndt, Anke; Belgian Cancer Registry, Koningsstraat 215, Box 7, 1210 Brussels, Belgium. Electronic address: Anke.DeGeyndt@kankerregister.org
Jacomen, Gerd; Laboratory of Pathological Anatomy, AZ Sint-Maarten, Liersesteenweg 435, 2800 Mechelen, Belgium. Electronic address: Gerd.Jacomen@emmaus.be
de Jonge, Eric; Department of Obstetrics and Gynecology, Ziekenhuis Oost-Limburg, Campus Sint-Jan, Synaps Park 1, 3600 Genk, Belgium. Electronic address: Eric.DeJonge@zol.be
Goffin, Frédéric ; Centre Hospitalier Universitaire de Liège - CHU > > Service de gynécologie-obstétrique (CHR)
Denys, Hannelore; Department of Medical Oncology, University Hospital Ghent, Corneel Heymanslaan 10, 9000 Ghent, Belgium. Electronic address: Hannelore.Denys@UGent.be
Amant, Frédéric; Unit of Gynecologic Oncology, Department of Oncology, KU Leuven, Campus Gasthuisberg, ON4 Herestraat 49, Box 1045, 3000 Leuven, Belgium, Department of Surgery, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands, Department of Gynecologic Oncology, UZ Leuven, Campus Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium. Electronic address: frederic.amant@kuleuven.be
Language :
English
Title :
Practice patterns, time trends and quality of care of uterine cancer in Belgium: An analysis of the EFFECT database.
This study was funded by Kom op tegen Kanker, Brussels, Belgium (grant number: KotK/2018/11467/1 ). From 2012 to 2016, the EFFECT project was financially supported by the Anticancer Fund, Meise, Belgium (grant number: A11 ). Through the employment of Gauthier Bouche, the Anticancer Fund was involved in study design and the writing of this manuscript. Kom op tegen Kanker had no such involvement, nor any other involvement.The authors particularly thank all participating Belgian hospitals for voluntarily registering this valuable and comprehensive set of data in the project-specific EFFECT database. We also thank the Belgian Cancer Registry for collecting and maintaining the project-specific EFFECT database, as well as for linking it to both its own database and that of the InterMutualistic Agency. Finally, many thanks to both Kom op tegen Kanker for funding this study (grant number: KotK/2018/11467/1) and the Anticancer Fund for financially supporting the EFFECT project from 2012 to 2016 (grant number: A11).
Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca-a Cancer J. Clin. 71:3 (2021), 209–249, 10.3322/caac.21660.
Morice, P., Leary, A., Creutzberg, C., Abu-Rustum, N., Darai, E., Endometrial cancer. Lancet. 387:10023 (2016), 1094–1108, 10.1016/S0140-6736(15)00130-0.
Belgian Cancer Registry, Absolute Number of Invasive Tumors by Primary Site and Age Group Among Belgian Females in 2021 Available online from: https://kankerregister.org Accessed July 2023.
Belgian Cancer Registry, Evaluation of the Quality of Care of Endometrial Cancer in Belgium – EFFectiveness of Endometrial Cancer Treatment (EFFECT) Project Available online from: https://kankerregister.org Accessed May 2023.
Werbrouck, J., Bouche, G., de Jonge, E., Jacomen, G., D'Hondt, V., Denys, H., et al. Evaluation of the quality of the management of cancer of the corpus uteri – selection of relevant quality indicators and implementation in Belgium. Gynecol. Oncol. 131:3 (2013), 512–519, 10.1016/j.ygyno.2013.10.001.
Vanbraband, J., Van Damme, N., Bouche, G., Silversmit, G., De Geyndt, A., de Jonge, E., et al. Completeness and selection bias of a Belgian multidisciplinary, registration-based study on the EFFectiveness and quality of Endometrial Cancer Treatment (EFFECT). BMC Cancer, 22(1), 2022, 13, 10.1186/s12885-022-09671-5.
Concin, N., Planchamp, F., Abu-Rustum, N.R., Ataseven, B., Cibula, D., Fagotti, A., et al. European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinoma. Int. J. Gynecol. Cancer 31:12 (2021), 1508–1529, 10.1136/ijgc-2021-003178.
Healthcare Improvement Scotland, NHS Scotland, Endometrial Cancer Clinical Quality Performance Indicators. Available online from: https://www.healthcareimprovementscotland.org/our_work/cancer_care_improvement/cancer_qpis/quality_performance_indicators.aspx.
Jegou, D., Dubois, C., Schillemans, V., Stordeur, S., De Gendt, C., Camberlin, C., et al. Use of health insurance data to identify and quantify the prevalence of main comorbidities in lung cancer patients. Lung Cancer 125 (2018), 238–244, 10.1016/j.lungcan.2018.10.002.
Burke, W.M., Orr, J., Leitao, M., Salom, E., Gehrig, P., Olawaiye, A.B., et al. Endometrial cancer: a review and current management strategies: Part I. Gynecol. Oncol. 134:2 (2014), 385–392, 10.1016/j.ygyno.2014.05.018.
Burke, W.M., Orr, J., Leitao, M., Salom, E., Gehrig, P., Olawaiye, A.B., et al. Endometrial cancer: a review and current management strategies: Part II. Gynecol. Oncol. 134:2 (2014), 393–402, 10.1016/j.ygyno.2014.06.003.
Colombo, N., Preti, E., Landoni, F., Carinelli, S., Colombo, A., Marini, C., et al. Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 24 (2013), 33–38, 10.1093/annonc/mdt353.
Colombo, N., Creutzberg, C., Amant, F., Bosse, T., Gonzalez-Martin, A., Ledermann, J., et al. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up. Ann. Oncol. 27:1 (2016), 16–41, 10.1093/annonc/mdv484.
Concin, N., Matias-Guiu, X., Vergote, I., Cibula, D., Mirza, M.R., Marnitz, S., et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Int. J. Gynecol. Cancer 31:1 (2021), 12–39, 10.1136/ijgc-2020-002230.
Information Services Division Scotland, NHS Scotland, Cervix and Endometrial Cancer Quality Performance Indicators for Patients Diagnosed between October 2014 and September 2017. Available online from: https://www.isdscotland.org/Health-Topics/Quality-Indicators/Publications/2018-12-18/2018-12-18-Cervix-and-Endometrial-QPI-Report.pdf.
Bixel, K., Barrington, D.A., Vetter, M.H., Suarez, A.A., Felix, A.S., Determinants of surgical approach and survival among women with endometrial carcinoma. J. Minim. Invasive Gynecol. 29:2 (2022), 219–230, 10.1016/j.jmig.2021.07.018.
Nieto, V.L., Huang, Y.M., Hou, J.Y., Tergas, A.I., St Clair, C.M., Ananth, C.V., et al. Use and outcomes of minimally invasive hysterectomy for women with nonendometrioid endometrial cancers. Am. J. Obstet. Gynecol., 219(5), 2018, 12, 10.1016/j.ajog.2018.07.028.
Cripe, J., Handorf, E., Brown, J., Jain, A., Rubin, S., Mantia-Smaldone, G., National cancer database report of lymphadenectomy trends in endometrial cancer. Int. J. Gynecol. Cancer 27:7 (2017), 1408–1415, 10.1097/IGC.0000000000001005.
Foote, J.R., Gaillard, S., Broadwater, G., Sosa, J.A., Davidson, B., Adam, M.A., et al. Disparities in the surgical staging of high-grade endometrial cancer in the United States. Gynecol. Oncol. Res. Pract., 4, 2017, 1, 10.1186/s40661-016-0036-3.
Wright, J.D., Huang, Y.M., Burke, W.M., Tergas, A.I., Hou, J.Y., Hu, J.C., et al. Influence of lymphadenectomy on survival for early-stage endometrial cancer. Obstet. Gynecol. 127:1 (2016), 109–118, 10.1097/AOG.0000000000001194.
Jou, J., Charo, L., Hom-Tedla, M., Coakley, K., Binder, P., Saenz, C., et al. Practice patterns and survival in FIGO 2009 stage 3B endometrial cancer. Gynecol. Oncol. 163:2 (2021), 299–304, 10.1016/j.ygyno.2021.09.005.
Akada, K., Koyama, N., Miura, T., Fukunaga, E., Miura, Y., Aoshima, K., et al. Real-world database analysis of the characteristics and treatment patterns of patients with endometrial cancer in Japan. Curr. Med. Res. Opin. 37:7 (2021), 1171–1178, 10.1080/03007995.2021.1903847.
Nasioudis, D., Heyward, Q., Gysler, S., Giuntoli, R.L., Cory, L., Kim, S., et al. Is there a benefit of performing an omentectomy for clinical stage I high-grade endometrial carcinoma?. Surg. Oncol. Oxford, 37, 2021, 5, 10.1016/j.suronc.2021.101534.
Gupta, V., McGunigal, M., Prasad-Hayes, M., Kalir, T., Liu, J., Adjuvant radiation therapy is associated with improved overall survival in high-intermediate risk stage I endometrial cancer: a national cancer data base analysis. Gynecol. Oncol. 144:1 (2017), 119–124, 10.1016/j.ygyno.2016.10.028.
Zakem, S.J., Robin, T.P., Smith, D.E., Amini, A., Stokes, W.A., Lefkowits, C., et al. Evolving trends in the management of high-intermediate risk endometrial cancer in the United States. Gynecol. Oncol. 152:3 (2019), 522–527, 10.1016/j.ygyno.2018.12.010.
McGunigal, M., Liu, J.T., Chadha, M., Gupta, V., Patterns of care for adjuvant therapy in high-intermediate-risk stage I endometrial cancer. Int. J. Radiat. Oncol. Biol. Phys., 96(2), 2016, 10.1016/j.ijrobp.2016.06.1422 E316-E.
Rydzewski, N.R., Strohl, A.E., Donnelly, E.D., Kanis, M.J., Lurain, J.R., Nieves-Neira, W., et al. Receipt of vaginal brachytherapy is associated with improved survival in women with stage I endometrioid adenocarcinoma of the uterus: a national cancer data base study. Cancer. 122:23 (2016), 3724–3731, 10.1002/cncr.30228.
Wong, A.T., Rineer, J., Schwartz, D., Weiner, J., Safdieh, J., Choi, K., et al. Patterns of adjuvant radiation usage and survival outcomes for stage I endometrial carcinoma in a large hospital-based cohort. Gynecol. Oncol. 144:1 (2017), 113–118, 10.1016/j.ygyno.2016.11.003.
Xiang, M., English, D.P., Kidd, E.A., National patterns of care and cancer-specific outcomes of adjuvant treatment in patients with serous and clear cell endometrial carcinoma. Gynecol. Oncol. 152:3 (2019), 599–604, 10.1016/j.ygyno.2018.12.007.
Polcher, M., Rottmann, M., Brugger, S., Mahner, S., Dannecker, C., Kiechle, M., et al. Lymph node dissection in endometrial cancer and clinical outcome: a population-based study in 5546 patients. Gynecol. Oncol. 154:1 (2019), 65–71, 10.1016/j.ygyno.2019.04.002.
Eggink, F.A., Mom, C.H., Boll, D., Ezendam, N.P.M., Kruitwagen, R., Pijnenborg, J.M.A., et al. Compliance with adjuvant treatment guidelines in endometrial cancer: room for improvement in high risk patients. Gynecol. Oncol. 146:2 (2017), 380–385, 10.1016/j.ygyno.2017.05.025.
